Search - tctmd.com

Displaying 21 - 40 of 67

Sort: Relevancy | Date

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Daily News

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Michael O'Riordan

August 10, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

News Conference News EHRA 2023

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Michael O'Riordan

April 19, 2023

News Conference News EHRA 2023

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

Michael O'Riordan

April 18, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

Advertisement

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Debating the Role of T-TEER in the Sickest Patients

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Reduced EF Evident in Some Elite Endurance Athletes

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content